五年内代表性文章（以通讯或第一作者发表，#共同第一，*共同通讯）:
1.Xu WW# * , Huang ZH#, Liao L, Zhang QH, Li JQ, Zheng CC, He Yan, Luo TT, Wang Y, Hu HF, Zuo Q, Chen WY, Yang QS, Zhao JF, Qin YR, Xu LY, Li EM, Liao HX, Li B*, He QY* (2020). Direct Targeting of CREB1 with Imperatorin Inhibits TGFβ2-ERK Signaling to Suppress Esophageal Cancer Metastasis. Advanced Science. 7(16):2000925. (一区, IF=15.8)
2.Xu WW#, Zheng CC#, Zuo Q, Li JQ, Hong P, Qin YR, Guan XY, He QY, Liao HX*, Li B*(2020). Genome-wide identification of key regulatory lncRNAs in esophageal cancer metastasis. Signal Transduction and Targed Therapy. Minor revision. (一区, IF=13.5)
3.Liao L#, Yao ZT#, Fang WK, He QY*, Xu WW*, Li B* (2020). Epigenetics in Esophageal Cancer: From Mechanisms to Therapeutics. Small Methods.4(10):202000391. (Review, IF=12.1)
4.Yang YM#, Hong P#, Xu WW*, He QY*, Li B* (2020). Advances in targeted therapy for esophageal cancer. Signal Transduction and Targed Therapy. 5:229. (Review, 一区, IF=13.5)
5.Hu HF, Xu WW, Zhang WX, Yan X, Li YJ, Li B*, He QY* (2020). Identification of miR-515-3p and its targets vimentin and MMP3 as a key regulatory mechanism in esophageal cancer metastasis: functional and clinical significance. Signal Transduction and Targed Therapy. 5:271. (一区, IF=13.5)
6.Hu HF, Xu WW, Li YJ, He Y, Zhang WX, Liao L, Zhang QH, Han L, Yin XF, Zhao XX, Pan YL, Li B*, He QY* (2020). Anti-allergic drug azelastine suppresses colon tumorigenesis by directly targeting ARF1 to inhibit IQGAP1-ERK-Drp1-mediated mitochondrial fission. Theranostics. doi:10.7150/thno.48698. (一区，IF=8.5)
7.Huang XH#, Yan X#, Zhang QH, Hong P, Zhang WX, Liu YP, Xu WW, Li B*, He QY* (2020). Direct targeting of HSP90 with daurisoline destabilizes β-catenin to suppress lung cancer tumorigenesis. Cancer Letters. 489:66-78. (一区, IF=7.4)
8.Hong P#, Liu QW#, Xie Y, Zhang QH, Liao L, He QY*, Li B*, Xu WW*. Echinatin suppresses esophageal cancer tumor growth and invasion through inducing AKT/mTOR-dependent autophagy and apoptosis (2020). Cell Death & Disease. 11(7):524. (二区, IF=6.3)
9.Wang Y, Zhang J, Li B*, He QY* (2019). Advance of proteomics on novel PTM discovery: the application in cancer therapy. Small Methods.3(5):1900041. (Review, IF=12.1)
10.Li B, Hong P, Zheng CC, Dai W, Chen WY, Yang QS, Han L, Tsao SW, Chan KT, Lee NPY, Law S, Xu LY, Li EM, Chan KW, Qin YR, Guan XY, Lung ML, He QY, Xu WW, Cheung AL (2019). Identification of miR-29c and its target FBXO31 as key regulatory mechanism in esophageal cancer chemoresistance-functional validation and clinical significance. Theranostics. 9(6):1599-1613. (一区，IF=8.5)
11.Yang J, Xu WW, Hong P, Ye F, Huang XH, Hu HF, Zhang QH, Yan X, Li B*, He QY* (2019). Adefovir dipivoxil sensitizes colon cancer cells to vemurafenib by disrupting the KCTD12-CDK1 interaction. Cancer Letters. 451:79-91.(一区, IF=7.4)
12.Zheng CC, Hu HF, Hong P, Yang J, Zhang QH, Xu WW, He QY*, Li B*(2019). Significance of integrin-linked kinase (ILK) in tumorigenesis and its potential implication as a biomarker and therapeutic target for human cancer. Am J Cancer Res.9(1):186-97. (Review, 二区, IF=5.2)
13.Huang XH, Wang Y, Hong P, Yang J, Zheng CC, Yin XF, Song WB, Xu WW, Li B*, He QY* (2019). Benzethonium chloride suppresses lung cancer tumorigenesis through inducing p38-mediated cyclin D1 degradation. Am J Cancer Res.9(11):2397-2412. (二区, IF=5.2)
14.Liu WT, Wang Y, Zhang J, Ye F, Huang XH, Li B*, He QY*. A novel strategy of integrated microarray analysis identifies CENPA, CDK1 and CDC20 as a cluster of diagnostic biomarkers in lung adenocarcinoma (2018). Cancer Letters. 425:43-53. (一区, IF=7.4)
15.Xu WW, Li B*, Zhao JF, Yang JG, Li JQ, Tsao SW, He QY, Cheung ALM*. IGF2 induces CD133 expression in esophageal cancer cells to promote cancer stemness (2018). Cancer Letters. 425:88-100. (一区, IF=7.4)
16.Yang J, Li B*, He QY*. Significance of prohibitin domain family in tumorigenesis and its implication in cancer diagnosis and treatment (2018). Cell Death & Disease. 9(6):580. (Review, 二区, IF=6.3)
17.Xu WW, Zheng CC, Huang Y, Chen WY, Yang QS, Ren JY, Wang YM, He QY, Liao HX*, Li B* (2018). Synephrine hydrochloride suppresses esophageal cancer tumor growth and metastatic potential through inhibition of Galectin-3-AKT/ERK signaling. J Agric Food Chem. 66(35):9248-58. (一区, IF=4.2)
18.Hu HF, Xu WW, Wang Y, Zheng CC, Zhang WX, Li B*, He QY* (2018). Comparative Proteomics Analysis Identifies Cdc42-Cdc42BPA Signaling as Prognostic Biomarker and Therapeutic Target for Colon Cancer Invasion. Journal of Proteome Research. 17(1):265-75. (二区, IF=4.1)
19.Wang Y, Li YJ, Huang XH, Zheng CC, Yin XF, Li B*, He QY* (2018). Liensinine perchlorate inhibits colorectal cancer tumorigenesis by inducing mitochondrial dysfunction and apoptosis. Food & Function. 9(11):5536-46. (一区, IF=4.2)
20.Xu WW#, Li B#, Guan XY, Chung SK, Wang Y, Yip YL, Law S, Chan KT, Lee PY, Chan KW, Xu LY, Li EM, Tsao SW, He QY*, Cheung AL* (2017). Cancer cell-secreted IGF2 instigates fibroblasts and bone marrow-derived vascular progenitor cells to promote cancer progression. Nature Communications.8:14399. (一区, IF=12.4)
21.Zhong Y, Yang J, Xu WW, Wang Y, Zheng CC, Li B*, He QY* (2017).KCTD12 promotes tumorigenesis by facilitating CDC25B/CDK1/Aurora A-dependent G2/M transition.Oncogene. 36(44):6177-89. (一区，IF=8.0)
22.Li B#, Xu WW#, Han L, Chan KT, Tsao SW, Lee NP, Law S, Xu LY, Li EM, Chan KW, Qin YR, Guan XY, He QY, Cheung AL (2017). microRNA-377 suppresses initiation and progression of esophageal cancer by inhibiting CD133 and VEGF. Oncogene.36(28):3986-4000.(一区, IF=8.0)
23.Li B, Xu WW, Lam AK, Wang Y, Hu HF, Guan XY, Qin YR, Saremi N, Tsao SW, He QY, Cheung AL (2017). Significance of PI3K/AKT signaling pathway in esophageal cancer metastasis and its potential as a target for anti-metastasis therapy. Oncotarget.8(24):38755-66.
24.Wang Y, Zhang J, Huang ZH, Huang XH, Zheng WB, Yin XF, Li YL, Li B*, He QY* (2017). Isodeoxyelephantopin induces protective autophagy in lung cancer cells via Nrf2-SQSTM1/p62-keap1 feedback loop. Cell Death & Disease. 8(6):e2876. (二区, IF=6.3)
25.Wang Y#, Yu RY#, Zhang J, Zhang WX, Huang ZH, Hu HF, Li YL, Li B*, He QY* (2017). Inhibition of Nrf2 enhances the anticancer effect of 6-O-angeloylenolin in lung adenocarcinoma. Biochemical Pharmacology. 129(12):43-53. (二区, IF=5.0)
26.Zheng WB, Li YJ, Wang Y, Yang J, Zheng CC, Huang XH, Li B*, He QY* (2017). Propafenone suppresses esophageal cancer proliferation through inducing mitochondrial dysfunction. Am J Cancer Res.7(11):2245-56. (二区, IF=5.2)
27.Wang Y, Zhang J, Li B*, He QY* (2017). Proteomic analysis of mitochondria: biological and clinical progresses in cancer. Expert Rev Proteomics.14(10):891-903. (Invited Review，IF=3.6)
28.Li B#, Xu WW#, Guan XY, Qin YR, Law S, Lee NP, Chan KT, Tam PY, Li YY, Chan KW, Yuen HF, Tsao SW, He QY, Cheung AL (2016). Competitive binding between Id1 and E2F1 to Cdc20 regulates E2F1 degradation and transcriptional activation of IGF2 to promote esophageal cancer chemoresistance. Clinical Cancer Research. 22(5):1243-55. (一区, IF=10.2)
29.Li J#, Li B#, Xu WW, Chan KW, Guan XY, Qin YR, Lee NP, Chan KT, Law S, Tsao SW, Cheung AL (2016). Role of AMPK signaling in mediating the anti-cancer effects of silibinin in esophageal squamous cell carcinoma. Expert Opinion on Therapeutic Targets. 20(1):7-18. (二区, IF=5.5)
30.Wang Y, Huang ZH, Li YJ, He GW, Yu RY, Yang J, Liu WT*, Li B*, He QY* (2016). Dynamic quantitative proteomics characterization of TNF-α-induced necroptosis. Apoptosis. 21(12):1438-1446. (二区, IF=4.5)
31.Li B, Tsao SW, Chan KW, Ludwig DL, Novosyadlyy R, Li YY, He QY, Cheung AL (2014). Id1-induced IGF2 and its autocrine/endocrine promotion of esophageal cancer growth and metastasis-Implications for IGF1R-targeted therapy. Clinical Cancer Research.20(10):2651-62. (一区, IF=10.2) (Featured Article in highlight of the issue, AACR Editor’s Picks, and MDLink)